论文部分内容阅读
目的探讨复方丹参注射液联合脑蛋白水解物治疗新生儿缺氧缺血性脑病的治疗效果。方法中度新生儿缺氧缺血性脑病90例,随机分为复方丹参治疗组,脑蛋白水解物治疗组,复方丹参联合脑蛋白水解物观察组,3组均采用支持治疗、对症处理基础上分别加用复方丹参、脑蛋白水解物、复方丹参联合脑蛋白水解物。结果复方丹参联合脑蛋白水解物观察组治疗新生儿缺氧缺血性脑病症状缓解快,为防止后遗症创造了条件,疗效分别与复方丹参组、脑蛋白水解物组相比,经统计学处理,差异有显著性意义(P＜0．05)。结论复方丹参联合脑蛋白水解物能提高治疗新生儿缺氧缺血性脑病的治疗效果。
Objective To investigate the therapeutic effect of compound Danshen injection combined with brain protein hydrolyzate on neonatal hypoxic-ischemic encephalopathy. Methods 90 cases of moderate neonatal hypoxic-ischemic encephalopathy were randomly divided into compound salvia miltiorrhiza treatment group, brain protein hydrolyzate treatment group and compound salvia miltiorrhiza combined with brain protein hydrolysates observation group. The three groups were treated with supportive therapy and symptomatic treatment Respectively with compound Salvia, brain protein hydrolyzate, compound Danshen brain protein hydrolyzate. Results Compound Danshen combined brain hydrolysates observation group treatment of neonatal hypoxic-ischemic encephalopathy relieved quickly to prevent sequelae to create the conditions, efficacy and compound Salvia group, brain protein hydrolyzate group compared to the statistical analysis, The difference was significant (P <0.05). Conclusion Compound Danshen combined with brain protein hydrolyzate can improve the treatment of neonatal hypoxic-ischemic encephalopathy.